The two treatments, Cibinqo and Staquis, cater to different stages of the condition, providing patients with more options to manage their symptoms and improve their quality of life. Staquis ...

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

Eucrisa/Staquis, and Cibinqo brands Amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands Goldman Sachs has a $32 price target for the shares.

Investors and now Wall Street love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential. Total return includes ...

It turned down Pfizer’s Staquis (crisaborole) – also sold as Eucrisa in some markets including the US – as a second-line treatment for mild to moderate atopic dermatitis, and Celgene’s ...

Pfizer also got the nod for Staquis (crisaborole), a topical phosphodiesterase 4 (PDE-4) inhibitor for atopic dermatitis already sold as Eucrisa in the US since 2016. The US drugmaker also had a ...

Nearly 28 years have passed, and the Grand Theft Auto (GTA) franchise has consistently maintained its core identity, which is reflected even in its logos. While the highly anticipated next installment ...

Recent data indicates that Wall Street money managers are rotating from low-dividend to high-dividend stocks. This rotation is the largest on record and is likely to continue through 2025 and ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...